These compounds may interact with:

Mitogen-activated protein kinase 1

Potentially involved in: multiple sclerosis; carcinoma; cancer; lyme disease; vascular disease; chromosome 22q11.2 deletion syndrome, distal; arthritis; neurodegenerative disease; gastrointestinal system disease; acquired immunodeficiency syndrome; bipolar disorder; squamous cell carcinoma; brain ischemia; enophthalmos; fetal growth retardation; flatfoot; gliosis; head and neck neoplasms; hyperalgesia; hypertrophy

Disease data sourced from Pharos.